322 related articles for article (PubMed ID: 34040908)
1. Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis.
Lewars J; Wazir H; Gordon B; Faluyi U; Girgis Y
Cureus; 2021 Apr; 13(4):e14608. PubMed ID: 34040908
[TBL] [Abstract][Full Text] [Related]
2. Transthyretin cardiac amyloidoses in older North Americans.
Dharmarajan K; Maurer MS
J Am Geriatr Soc; 2012 Apr; 60(4):765-74. PubMed ID: 22329529
[TBL] [Abstract][Full Text] [Related]
3. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
4. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
Manolis AS; Manolis AA; Manolis TA; Melita H
Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.
Ton VK; Mukherjee M; Judge DP
Clin Med Insights Cardiol; 2014; 8(Suppl 1):39-44. PubMed ID: 25628512
[TBL] [Abstract][Full Text] [Related]
6. Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy.
Murat S; Çavuşoğlu Y; Ak Sivrikoz İ
Turk Kardiyol Dern Ars; 2021 Oct; 49(7):579-584. PubMed ID: 34623301
[TBL] [Abstract][Full Text] [Related]
7. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.
Siddiqi OK; Ruberg FL
Trends Cardiovasc Med; 2018 Jan; 28(1):10-21. PubMed ID: 28739313
[TBL] [Abstract][Full Text] [Related]
8. Light-Chain (AL) Cardiac Amyloidosis Presenting as Heart Failure With Reduced Ejection Fraction.
Santiago LE; Alvi AT; Melnychuk V; Mesquita P; Aneja P
Cureus; 2024 Feb; 16(2):e55271. PubMed ID: 38558722
[TBL] [Abstract][Full Text] [Related]
9. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
Di Giovanni B; Gustafson D; Delgado DH
Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
[No Abstract] [Full Text] [Related]
10. Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure.
Molina O G; Judge D; Campbell W; Chahal H; Mugmon M
J Community Hosp Intern Med Perspect; 2014; 4(5):25500. PubMed ID: 25432650
[TBL] [Abstract][Full Text] [Related]
11. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
12. Senile Systemic Amyloidosis: An Underdiagnosed Disease.
Manso MC; Marques DP; Rocha SL; Rodeia SC; Domingos R
Eur J Case Rep Intern Med; 2017; 4(9):000725. PubMed ID: 30755970
[TBL] [Abstract][Full Text] [Related]
13. Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
Thenappan T; Fedson S; Rich J; Murks C; Husain A; Pogoriler J; Anderson AS
Amyloid; 2014 Jun; 21(2):120-3. PubMed ID: 24818650
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.
Smiley DA; Rodriguez CM; Maurer MS
Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137
[TBL] [Abstract][Full Text] [Related]
15. Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
Hesse A; Altland K; Linke RP; Almeida MR; Saraiva MJ; Steinmetz A; Maisch B
Br Heart J; 1993 Aug; 70(2):111-5. PubMed ID: 8038017
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.
Devesa A; Camblor Blasco A; Pello Lázaro AM; Askari E; Lapeña G; Gómez Talavera S; Taibo Urquía M; Rodríguez Olleros C; Tuñón J; Ibáñez B; Aceña Á
ESC Heart Fail; 2021 Aug; 8(4):2856-2865. PubMed ID: 33963812
[TBL] [Abstract][Full Text] [Related]
17. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
18. [Dyspnea and edema in a 79-year old male].
Schwarz F; Klingel K; Greulich S; Gawaz M
Inn Med (Heidelb); 2022 Sep; 63(9):994-999. PubMed ID: 35925120
[TBL] [Abstract][Full Text] [Related]
19. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
20. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
